Literature DB >> 22507803

Comprehensive care in hemophilia.

Arlette Ruiz-Sáez1.   

Abstract

Hemophilia is a chronic and inherited X-linked bleeding disorder that requires life-long medical care. Hemophilia treatment is costly and complex partly because of the cost of the factor concentrates used in replacement therapy. However, the management of hemophilia is not based solely on achieving access to better treatment with safe factor concentrates; it also includes accurately diagnosing the disorder and providing specialized comprehensive care by a multidisciplinary team of specialists trained in hemophilia management. Comprehensive care for the person with hemophilia is defined as the continuous supervision of all medical and psychological aspects affecting the patient and his family and it demands the establishment of specialized centers, called Hemophilia Treatment Centers. The services that should be offered by a comprehensive hemophilia healthcare center are diverse and the multidisciplinary team should be coordinated preferably by a hematologist with the participation of other health professionals. It has been demonstrated that the benefits of establishing hemophilia centers are observed even in developing countries and that changes can be achieved when resources are re-organized, especially when education and training are provided at all levels. To reach these objectives, it is essential to have the participation of the patient and family members, and to strive to obtain the financial and legislative support from the State or Government in order to achieve a national comprehensive care program contemplating all the aspects needed for improving the quality of life for the community of patients with hemophilia and other bleeding disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22507803     DOI: 10.1179/102453312X13336169156492

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  5 in total

1.  Management of Haemophilia in Developing Countries: Challenges and Options.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2015-06-18       Impact factor: 0.900

Review 2.  Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment.

Authors:  Paula James; Raj Kasthuri; Rebecca Kruse-Jarres; Amit Soni; Roshni Kulkarni; Christoph Bidlingmaier; Meera Chitlur; Patrick Fogarty; Keith Gomez; Pål Andrè Holm; Johnny Mahlangu; Maria Elisa Mancuso; Maria Eva Mingot-Castellano; Gerry Dolan
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

3.  Impact of the 340B Pharmacy Program on Services and Supports for Persons Served by Hemophilia Treatment Centers in the United States.

Authors:  Rebecca A Malouin; Laurel Mckernan; Ann Forsberg; Dunlei Cheng; John Drake; Kathryn McLaughlin; Marisela Trujillo
Journal:  Matern Child Health J       Date:  2018-09

4.  Challenges facing community-dwelling adults with hemophilia: Implications for community-based adult education and nursing.

Authors:  Charity Chinelo Okide; Chiedu Eseadi; Uzoamaka Lucynda Koledoye; Felicia Mbagwu; Nwakaego Ebele Ekwealor; Nkechi Mercy Okeke; Chioma Osilike; Polycarp M D Okeke
Journal:  J Int Med Res       Date:  2019-07-16       Impact factor: 1.671

Review 5.  The Need for Comprehensive Care for Persons with Chronic Immune Thrombocytopenic Purpura.

Authors:  Kristin T Ansteatt; Chanel J Unzicker; Marsha L Hurn; Oluwaseun O Olaiya; Diane J Nugent; Michael D Tarantino
Journal:  J Blood Med       Date:  2020-12-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.